| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.04B | 39.97B | 39.73B | 39.57B | 36.74B | 35.64B |
| Gross Profit | 12.08B | 11.99B | 12.07B | 11.61B | 10.73B | 10.04B |
| EBITDA | 3.19B | 3.36B | 3.66B | 3.40B | 2.56B | 2.22B |
| Net Income | 1.45B | 1.47B | 1.70B | 1.48B | 1.14B | 915.00M |
Balance Sheet | ||||||
| Total Assets | 53.18B | 53.24B | 54.08B | 50.76B | 49.38B | 47.52B |
| Cash, Cash Equivalents and Short-Term Investments | 14.15B | 14.18B | 11.20B | 12.12B | 12.34B | 11.53B |
| Total Debt | 1.09B | 1.08B | 1.19B | 926.00M | 691.00M | 931.00M |
| Total Liabilities | 15.92B | 15.72B | 16.91B | 16.50B | 16.12B | 15.23B |
| Stockholders Equity | 36.65B | 36.60B | 36.33B | 33.52B | 32.60B | 31.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.64B | 24.00M | 891.00M | 1.30B | 1.80B |
| Operating Cash Flow | 0.00 | 4.43B | 795.00M | 1.78B | 2.06B | 2.59B |
| Investing Cash Flow | 0.00 | -381.00M | -817.00M | -908.00M | -753.00M | -777.00M |
| Financing Cash Flow | 0.00 | -1.15B | -978.00M | -1.19B | -631.00M | -626.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥100.68B | 0.94 | ― | 4.28% | 12.87% | -13.69% | |
76 Outperform | ¥17.22B | 7.85 | ― | 2.81% | 0.23% | -8.64% | |
75 Outperform | ¥17.86B | 7.05 | ― | 3.09% | 0.27% | 7.57% | |
75 Outperform | ¥146.80B | 9.90 | ― | 1.92% | 12.72% | 28.48% | |
68 Neutral | ¥112.23B | 25.05 | ― | 2.17% | -2.39% | -29.17% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥71.09B | 12.73 | ― | 3.27% | 12.09% | 5.46% |